Sid Sijbrandij (pronounced “see-brandy”), the co-founder of GitLab, was diagnosed with bone cancer and found himself running out of treatment options when the cancer returned in 2024.
After doctors essentially told him “good luck,” he decided to take ownership. What followed was impressive – He assembled a team, built a 1,000+ page health document modeled after the GitLab Handbook, and pursued what he calls “maximal diagnostics” – doing every test available, as often as possible.
Armed with that data, he identified experimental therapies, navigated the FDA for compassionate use access, and flew to Germany for a cutting-edge radioligand therapy that targeted his specific tumor markers. His cancer is now in remission.

He has documented his entire journey here (this story has a lot of the details too).
While Sid is undoubtedly fortunate to have incredible resources as someone whose net worth is in the hundreds of millions of dollars (or more), this is a glimpse of where cancer care is heading – personalized diagnostics, custom therapies, AI-driven drug discovery. He also highlights the aspects of the system that are broken – e.g., getting his own tissue samples and genomic data.
And, as he called out, the basics are not prohibitively expensive.

We have more agency than we think – especially with the tools available to us today.
